Dr. Apel Medizinische Versorgung GmbH
- Address
- Bahnhofstrasse 46, Erfurt-Altstadt, 99084 Erfurt, Germany
Dr. Apel Medizinische Versorgung GmbH - Breast Cancer Research Center
Dr. Apel Medizinische Versorgung GmbH is a specialized medical research facility focused on advancing treatment options for breast cancer patients. The center demonstrates particular expertise in conducting complex oncology trials that evaluate novel therapeutic combinations and targeted therapies across different breast cancer subtypes.
- HER2-positive breast cancer with high-risk features following preoperative therapy
- Estrogen receptor-positive, HER2-negative locally advanced or metastatic breast cancer
- Combination immunotherapy and antibody-drug conjugate strategies in early-stage disease
- Next-generation endocrine therapies for CDK4/6 inhibitor-resistant disease
The center's research portfolio includes studies evaluating atezolizumab combined with trastuzumab emtansine in the adjuvant setting, as well as investigations of giredestrant plus everolimus for endocrine-resistant breast cancer. This dual focus on both early-stage high-risk populations and advanced disease reflects the facility's commitment to addressing critical unmet needs across the breast cancer treatment continuum, particularly for patients with ESR1 mutations and those who have progressed on standard endocrine therapy combinations.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Top 2 therapeutic areas and 15 of 17 IMPs, ranked by number of trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 1 by active trials.
- 1F. Hoffmann-La Roche AG1active
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
- 1F. Hoffmann-La Roche AG2trials
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 2 161 other sites in Germany
Therapeutic Area Benchmark — Germany
Select a therapeutic area to compare against other sites in Germany.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Germany
Market Share
Country: Germany
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Dr. Apel Medizinische Versorgung GmbH
lock Showing 1 of 3 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Efficacy and Safety of Giredestrant Plus Everolimus Versus Endocrine Therapy Plus Everolimus in ER-Positive, HER2-Negative Advanced Breast Cancer | Genentech Inc. | Phase III | Not Recruiting | Oct 2023 | — |
IMP list
lock Showing 1 of 17 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Exemestane | 2 | Unknown | 2023-10-12 | 2023-12-22 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.